APA (7th ed.) Citation

Onishi, T., Maeda, R., Terada, M., Sato, S., Fujii, T., Ito, M., . . . Tanaka, M. (2021). A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer’s disease and tauopathy in mice. Nature Portfolio.

Chicago Style (17th ed.) Citation

Onishi, Tomohiro, Ryouta Maeda, Michiko Terada, Sho Sato, Takahiro Fujii, Masahiro Ito, Kentaro Hashikami, Tomohiro Kawamoto, and Maiko Tanaka. A Novel Orally Active HDAC6 Inhibitor T-518 Shows a Therapeutic Potential for Alzheimer’s Disease and Tauopathy in Mice. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Onishi, Tomohiro, et al. A Novel Orally Active HDAC6 Inhibitor T-518 Shows a Therapeutic Potential for Alzheimer’s Disease and Tauopathy in Mice. Nature Portfolio, 2021.